Foyston Gordon & Payne Inc Has $4.35 Million Holdings in CME Group Inc. (NASDAQ:CME)

Foyston Gordon & Payne Inc decreased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 1.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,116 shares of the financial services provider’s stock after selling 300 shares during the quarter. Foyston Gordon & Payne Inc’s holdings in CME Group were worth $4,348,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. International Assets Investment Management LLC bought a new position in shares of CME Group in the fourth quarter valued at $27,986,000. Kestra Private Wealth Services LLC increased its position in CME Group by 115.5% during the fourth quarter. Kestra Private Wealth Services LLC now owns 5,294 shares of the financial services provider’s stock worth $1,115,000 after buying an additional 2,837 shares during the last quarter. Certuity LLC bought a new stake in CME Group in the fourth quarter valued at approximately $202,000. MONECO Advisors LLC bought a new position in shares of CME Group during the 4th quarter worth approximately $226,000. Finally, Victory Capital Management Inc. raised its stake in CME Group by 5.2% in the 4th quarter. Victory Capital Management Inc. now owns 214,269 shares of the financial services provider’s stock valued at $45,125,000 after acquiring an additional 10,497 shares during the period. Institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on CME shares. JPMorgan Chase & Co. upped their price target on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Piper Sandler reiterated an “overweight” rating and set a $225.00 target price on shares of CME Group in a research note on Tuesday, August 20th. Barclays increased their price objective on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft upped their price target on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research note on Thursday, August 15th. Finally, Keefe, Bruyette & Woods boosted their price objective on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $213.27.

CME Group Stock Up 0.8 %

CME stock opened at $215.74 on Friday. The firm has a 50-day moving average price of $201.36 and a 200-day moving average price of $207.43. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $223.80. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $77.68 billion, a P/E ratio of 24.54, a price-to-earnings-growth ratio of 6.51 and a beta of 0.52.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company’s quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter last year, the business posted $2.30 earnings per share. As a group, equities research analysts anticipate that CME Group Inc. will post 9.89 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be given a $1.15 dividend. The ex-dividend date is Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.13%. CME Group’s dividend payout ratio is presently 52.33%.

Insider Activity

In related news, Director Charles P. Carey sold 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of $195.44, for a total value of $586,320.00. Following the completion of the transaction, the director now owns 7,163 shares in the company, valued at approximately $1,399,936.72. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction that occurred on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the transaction, the director now directly owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Daniel R. Glickman sold 650 shares of the stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $201.44, for a total transaction of $130,936.00. Following the sale, the director now directly owns 14,008 shares of the company’s stock, valued at approximately $2,821,771.52. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.